国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (8): 621-624.

• 综述 • 上一篇    下一篇

原发性中枢神经系统淋巴瘤的诊断和治疗

李小优, 冯继锋   

  1. 210009南京,江苏省肿瘤医院内科211病区
  • 出版日期:2013-08-08 发布日期:2013-08-15
  • 通讯作者: 冯继锋,E-mail:fjifsina@126.com E-mail:fjifsina@126.com

Diagnosis and treatment of primary central nervous system lymphoma

LI  Xiao-You, FENG  Ji-Feng   

  1. Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing 210009, China, Nanjing 210009, China

  • Online:2013-08-08 Published:2013-08-15
  • Contact: FENG Ji-feng, E-mail:fjifsina@126.com E-mail:fjifsina@126.com

摘要: 原发性中枢神经系统淋巴瘤(PCNSL)是一种较罕见的中枢神经系统恶性肿瘤,其生物学行为具有侵袭性,临床无典型性,病理形态存在异质性,影像表现多样性,依靠病理免疫组织化学及分子生物学方可确诊。各种以大剂量甲氨蝶呤为基础的治疗方案,改善了PCNSL的治疗效果,并成为PCNSL的标准治疗措施,患者的生存率较单用放疗得以显著地提高。早期诊断,并进行有效的综合治疗是延长PCNSL患者生存期和改善生活质量的关键。

关键词: 中枢神经系统肿瘤, 淋巴瘤, 诊断, 治疗

Abstract: Primary central nervous system lymphoma ( PCNSL) is a rare form of non-Hodgkin lymphoma ( NHL) and has aggressive biological behavior. Due to absence of typical clinical presentation,heterogeneity of pathological morphology and multiple neuroimaging appearance and so on,the immunohistochemistry and molecular biology are of vital importance in accurate diagnosis of PCNSL. The development of regimen based on high-dose MTX leads to significant changes in the PCNSL treatment and it has become a generally recognized regimen. Compared with single radiotherapy, the survival rate has evidently been raised. Early diagnosis and surgical removal of the tumors combined with effective radiotherapy and chemo- therapy are the key to extending survival period and improving living quality of patients with PCNSL.

Key words: Central nervous system neoplasms, Lymphoma, Diagnosis, Therapy